28 related articles for article (PubMed ID: 9165205)
1. Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H.
Xiao Q; Dong N; Yao X; Wu D; Lu Y; Mao F; Zhu J; Li J; Huang J; Chen A; Huang L; Wang X; Yang G; He G; Xu Y; Lu W
Sci Rep; 2016 Apr; 6():25298. PubMed ID: 27126280
[TBL] [Abstract][Full Text] [Related]
2. Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG.
Brasch J; Becker D; Aberer W; Bircher A; Kränke B; Jung K; Przybilla B; Biedermann T; Werfel T; John SM; Elsner P; Diepgen T; Trautmann A; Merk HF; Fuchs T; Schnuch A
Allergo J Int; 2014; 23(4):126-138. PubMed ID: 26146602
[No Abstract] [Full Text] [Related]
3. [Contact allergy in children].
Brasch J
Hautarzt; 2009 Mar; 60(3):194-6, 198-9. PubMed ID: 19238342
[TBL] [Abstract][Full Text] [Related]
4. [Bufexamac-induced pigmented purpuric eruption].
Waltermann K; Marsch WCh; Kreft B
Hautarzt; 2009 May; 60(5):424-7. PubMed ID: 19093092
[TBL] [Abstract][Full Text] [Related]
5. [Pruritus in pregnancy. A frequent diagnostic and therapeutic challenge].
Weisshaar E; Witteler R; Diepgen TL; Luger TA; Ständer S
Hautarzt; 2005 Jan; 56(1):48-57. PubMed ID: 15536515
[TBL] [Abstract][Full Text] [Related]
6. [Pruritus in childhood. A diagnostic and therapeutic challenge].
Weisshaar E; Seeliger S; Diepgen TL; Luger TA; Ständer S
Hautarzt; 2004 Sep; 55(9):855-68. PubMed ID: 15340711
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiologic surveillance of contact allergens. The "monitoring series" of IVDK (Information Network ofDermatologic Clinics for Detection and Scientific Evaluation of Contact Allergy].
Aberer W; Komericki P; Uter W; Hausen BM; Lessmann H; Kränke B; Geier J; Schnuch A
Hautarzt; 2003 Aug; 54(8):741-9. PubMed ID: 12942188
[TBL] [Abstract][Full Text] [Related]
8. [Contact sensitization to external agents].
Erdmann SM; Merk HF
Hautarzt; 2003 Apr; 54(4):331-7. PubMed ID: 12669204
[TBL] [Abstract][Full Text] [Related]
9. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases.
Koch P; Bahmer FA
Contact Dermatitis; 1994 Aug; 31(2):97-101. PubMed ID: 7750277
[TBL] [Abstract][Full Text] [Related]
10. [A severe epicutaneous test reaction to the bufexamac in a hemorrhoidal therapeutic preparation].
Bauer A; Greif C; Gebhardt M; Elsner P
Dtsch Med Wochenschr; 1999 Oct; 124(40):1168-70. PubMed ID: 10548947
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
[TBL] [Abstract][Full Text] [Related]
12. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Schnuch A; Gefeller O; Uter W
Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
[TBL] [Abstract][Full Text] [Related]
13. Bufexamac is a frequent contact sensitizer.
Kränke B; Derhaschnig J; Komericki P; Aberer W
Contact Dermatitis; 1996 Jan; 34(1):63-4. PubMed ID: 8789232
[No Abstract] [Full Text] [Related]
14. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
Proske S; Uter W; Schnuch A; Hartschuh W
Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
[TBL] [Abstract][Full Text] [Related]
15. Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
Barbaud A; Tréchot P; Aublet-Cuvelier A; Reichert-Penetrat S; Schmutz JL
Contact Dermatitis; 1998 Nov; 39(5):272-3. PubMed ID: 9840280
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
